Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Incyte grabs control of a cancer drug from Calithera’s pipeline for $53M up front
Incyte grabs control of a cancer drug from Calithera’s pipeline for $53M up front
Incyte grabs control of a cancer drug from Calithera’s pipeline for $53M up front
Submitted by
admin
on January 30, 2017 - 10:19am
Source:
Endpoints
News Tags:
Inctye
Calithera
CB-1158
immuno-oncology
Headline:
Incyte grabs control of a cancer drug from Calithera’s pipeline for $53M up front
Do Not Allow Advertisers to Use My Personal information
